Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRH of Belbuca vs Oxycodone in Recreational Opioid Users
NCT03996694Phase 1Completed
- Sponsor
- BioDelivery Sciences International
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BEMA buprenorphine in chronic pain (6 arms), sponsored by BioDelivery Sciences International. Primary endpoint: Ventilatory Response to Hypercapnia (VRH) at 4 hours. Started Jul 2019; status: completed.
02
Drugs
BEMA buprenorphine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03996694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996694.